Loading...
XNYS
JNJ
Market cap649bUSD
Sep 21, Last price  
269.47USD
1D
-0.19%
1Q
12.71%
Jan 2017
133.89%
Name

Johnson & Johnson

Chart & performance

D1W1MN
XNYS:JNJ chart
P/E
24.23
P/S
6.89
EPS
11.12
Div yield, %
1.91%
Shrs. gr., 5y
-1.88%
Rev. gr., 5y
2.67%
Revenues
94.19b
+6.05%
67,224,000,00071,312,000,00071,312,000,00074,331,000,00074,331,000,00070,074,000,00070,074,000,00071,890,000,00071,890,000,00076,450,000,00081,581,000,00081,581,000,00082,059,000,00082,059,000,00082,584,000,00078,740,000,00079,990,000,00085,159,000,00088,821,000,00094,193,000,000
Net income
26.80b
+90.56%
10,853,000,00013,831,000,00013,831,000,00016,323,000,00016,323,000,00015,409,000,00015,409,000,00016,540,000,00016,540,000,0001,300,000,00015,297,000,00015,297,000,00015,119,000,00015,119,000,00014,714,000,00020,878,000,00017,941,000,00035,153,000,00014,066,000,00026,804,000,000
CFO
24.53b
+1.09%
15,396,000,00017,414,000,00017,414,000,00018,471,000,00018,471,000,00019,279,000,00019,279,000,00018,767,000,00018,767,000,00021,056,000,00022,201,000,00022,201,000,00023,416,000,00023,416,000,00023,536,000,00023,410,000,00021,194,000,00022,791,000,00024,266,000,00024,530,000,000
Dividend
Aug 25, 20261.34 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Johnson & Johnson functions as a global healthcare enterprise, involved in the research, development, manufacturing, and commercialization of a wide spectrum of health-related products. Its activities are organized across three principal divisions: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment provides an extensive range of goods, encompassing baby care items under brands like JOHNSON'S and AVEENO Baby, oral hygiene products such as LISTERINE, and skin/beauty solutions from AVEENO, NEUTROGENA, and OGX. It also offers over-the-counter medications for various ailments, including pain relief (TYLENOL, MOTRIN IB), cold, flu, and allergy symptoms (SUDAFED, BENADRYL, ZYRTEC), smoking cessation aids (NICORETTE), and acid reflux treatments (PEPCID). Additionally, this division includes women's health products like STAYFREE and o.b., wound care essentials such as BAND-AID adhesive bandages, and NEOSPORIN for first aid. The Pharmaceutical segment is dedicated to developing therapies within significant therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic disorders. The Medical Devices segment delivers sophisticated solutions for cardiovascular conditions, including electrophysiology and neurovascular care for strokes. It also provides orthopaedic products supporting hips, knees, trauma, spine, and sports-related needs, alongside advanced and general surgical solutions focusing on breast aesthetics and ear, nose, and throat procedures. Furthermore, this segment offers ophthalmic products, notably ACUVUE brand disposable contact lenses and technologies for cataract and laser refractive surgery. The company distributes its products through diverse channels, reaching the general public via retail outlets and distributors, and directly supplying wholesalers, hospitals, and healthcare professionals for prescription-based use. Johnson & Johnson was established in 1886 and maintains its headquarters in New Brunswick, New Jersey.

Related entities

Subsidiaries (205)
Johnson & Johnson Middle East FZ-LLC
JOHNSON & JOHNSON SANTE BEAUTE FRANCE
JOHNSON & JOHNSON TAIWAN LTD.
JOHNSON & JOHNSON UK TREASURY COMPANY LIMITED
JOHNSON & JOHNSON VISION CARE (AUSTRALIA) PTY LTD
JOHNSON & JOHNSON VISION CARE IRELAND UNLIMITED COMPANY
JOHNSON & JOHNSON, PRODAJA MEDICINSKIH IN FARMACEVTSKIH IZDELKOV, D.O.O.
JOHNSON & JOHNSON, S.R.O.
JOHNSON Y JOHNSON DE CHILE S A
McNeil Consumer Pharmaceuticals Co.
MCNEIL NUTRITIONALS, LLC
McNeil Sweden AB
Medos International Sarl
MENTOR MEDICAL SYSTEMS B.V.
OMRIX BIOPHARMACEUTICALS
Omrix Biopharmaceuticals Ltd
PT JOHNSON & JOHNSON INDONESIA
RESPIVERT LTD.
SHOCKWAVE MEDICAL ITALY S.R.L.
Synthes GMBH

Key people

Chairman of the Board, Chief Executive Officer · since 2012
Vice Chairman - Executive Committee · since 2018
Peter M. Fasolo
Chief Human Resource Officer, Executive Vice President · since 2016
Executive Vice President - Worldwide Chairman, Medical Devices · since 2018
Thibaut Mongon
Executive Vice President, Worldwide Chairman, Consumer · since 2018
Jennifer L. Taubert
Executive Vice President - Worldwide Chairman, Pharmaceuticals · since 2018
Michael H. Ullmann
Executive Vice President, General Counsel · since 2016
Kathryn E. Wengel
Executive Vice President, Chief Global Supply Chain Officer · since 2018
Joseph J. Wolk
Chief Financial Officer, Executive Vice President · since 2018
Vice Chairman- Executive Committee, Chief Scientific Officer · since 2018
Lead Independent Director · since 2012
Independent Director · since 2015
Independent Director · since 2010
Independent Director · since 2016
Jennifer A. Doudna
Independent Director · since 2018
A. Eugene Washington
Independent Director · since 2012
IPO date
Sep 25, 1944
Employees
152,700
Domiciled in
US
Incorporated in
US
Headquarters & legal address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑002021‑002019‑122019‑122018‑122018‑122017‑122017‑002016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT